Early temporal changes in the uridine kinase isozyme profile of the Novikoff hepatoma in response to 5-azacytidine treatment.
D000375:Aging; D000818:Animals; D001374:Azacitidine / Q000494:pharmacology* / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy / Q000201:enzymology*; D004261:DNA Replication / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D005260:Female; D007527:Isoenzymes / Q000378:metabolism*; D008113:Liver Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000201:enzymology; D010770:Phosphotransferases / Q000378:metabolism*; D051381:Rats; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014541:Uridine Kinase / Q000378:metabolism*
D007527:Isoenzymes; D014316:Tritium; D010770:Phosphotransferases; D014541:Uridine Kinase; D001374:Azacitidine; D013936:Thymidine